Skip to main content
Equibles
HIT logo

HIT · Health In Tech, Inc. · Metrics

Track HIT — free

Use HIT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research HIT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$0.89 0.00 (-0.40%) At close · Sep 15
Rebalance outlook locked
Market Cap
$58.29M
Shares
65.53M

HIT metrics

58 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$0.89
Market cap
$58.29M

Price action

20 metrics
Price change (1W)
-9.2%
Price change (30D)
-11.9%
Price change (3M)
-15.3%
Price change (6M)
-48.0%
Price change (YTD)
-44.1%
Price change (1Y)
-66.3%
Trailing year
Price change (5Y)
—
52-week high
$3.77
52-week low
$0.87
Change from 52-week high
-76.4%
Change from 52-week low
+2.7%
Annualized volatility
97.4%
Annualized volatility (3M)
51.8%
Beta
1.3
RSI (14D)
31.8
Price vs SMA 50
-14.4%
Price vs SMA 200
-29.9%
Avg volume (3M)
75,658
Relative volume
0.7
Average dollar volume
$78,247

Company

3 metrics
Sector
Technology
Industry
Software - Application
Shares outstanding
65.53M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.8×
reciprocal yield 56.3%
P / book
3.0
reciprocal yield 33.7%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-6.8%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-13

Profitability

9 metrics
Gross margin
53.9%
Operating margin
—
Trailing 12 months
Net margin
-12.0%
Gross profit (TTM)
$17.70M
Operating profit (TTM)
—
Net income (TTM)
−$3.95M
Trailing 12 months
Diluted EPS (TTM)
$-0.07
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-13.5%
Year over year
Net income growth YoY
-498.2%
Revenue (TTM)
$32.83M
Trailing 12 months
EPS growth YoY
-500.0%
Shares change YoY
+12.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-20.1%
Return on assets
-13.3%
Debt / equity
—
Current ratio
2.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
2.2
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$6.51M
Latest balance sheet
Cash & equivalents
$6.51M
Total assets
$29.63M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$5.11M
Capital expenditures (TTM)
—
R&D (TTM)
$2.25M
SG&A (TTM)
—
Stock compensation (TTM)
$1.70M
R&D / revenue
6.8%
Stock compensation / revenue
5.2%

Ownership (13F)

3 metrics
13F filers
21
13F filer change QoQ
+7
Institutional ownership
7.1%

Short interest

3 metrics
Short interest
0.7%
Latest settlement · 6.8 days to cover
Days to cover
6.8d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$37,699
Insider-sentiment score
47 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 2019505 CUSIP 42217D102 13F (30d) 1 filings 1 filers Visit website Investor relations